14:45 - 16:30

Session 3 | Regulatory Environment for Biologics

Description:

Updates within the regulatory framework for biologic drugs and clinical trial development will be examined by this panel of experts, including the balance between public safety, access and maintaining proper incentives for innovation, as well as efforts to harmonize regulations with global best practices.

Moderator:

Speakers: